Strategy for Life Science towards 2030 in Denmark

In November 2024, the Danish Government presented a new Strategy for Life Science towards 2030. In this publication, the term "life science" covers several large areas, including medical biotechnology and medical equipment, health technology, medicinal products, aids, health applications, artificial intelligence (AI) solutions, etc.

The Strategy will strengthen the role of innovative health solutions in relation to freeing up labor and ensuring a sustainable healthcare system. The Vision is that Denmark must be a leading life science nation in Europe to benefit patients, the Danish healthcare system, and the Danish economy. Some of the specifically outlined initiatives and strategic landmarks include the following:

• Denmark must support new viable companies within life science to a greater extent;
• Through strengthened research and IT infrastructure, Denmark must translate the unique health data into ground-breaking research, the spread of artificial intelligence, and increased innovation for better patient treatment;
• Denmark must promote access to innovative, effective, and workforce-free health solutions and innovative medicines to improve citizens' health and future-proof the healthcare system. This includes establishing a health innovation index, the impact assessment of digital health solutions, further development of the data-driven model for value-based procurement, the analysis of alternative pricing models, promoting the development and commissioning of advanced therapies (e.g., gene therapies, cell therapies, and tissue technologies);
• Denmark must support framework conditions with a view to attracting more life science production and more foreign investment;
• Through focused health diplomacy and cooperation with the authorities, Denmark must continue to take an active international role in solving global health challenges and support the export of Danish health solutions;
• Denmark must be a strong player in the EU in order to support Europe as an attractive life science region and ensure Denmark's life science sector has a competitive regulatory framework.

Furthermore, the Government plans to establish a new National Center for Healthcare Innovation, which will strengthen the development and dissemination of innovative healthcare solutions to improve patient treatment and free up time for healthcare staff. With the center, the Government aims to break down barriers to spreading innovative health solutions and improve access to them. The center will be an independent organization anchored with Digital Health Denmark, the national operating and development organization jointly owned by municipalities, regions, and the state. The Government proposes to set aside two billion DKK over the next ten years to spread new digital solutions under the auspices of Digital Health Denmark and the National Center for Health Innovation. 

See the full details in Danish here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.